FSMDX
Price
$43.48
Change
-$0.36 (-0.82%)
Updated
Aug 20 closing price
Net Assets
52.09B
UMBMX
Price
$28.14
Change
+$0.19 (+0.68%)
Updated
Aug 21 closing price
Net Assets
4.26B
Interact to see
Advertisement

FSMDX vs UMBMX

FSMDX vs UMBMX Comparison Chart in %
View a ticker or compare two or three
VS
FSMDX vs. UMBMX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMDX is a Hold and UMBMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMDX has more cash in the bank: 52.1B vs. UMBMX (4.26B). FSMDX pays higher dividends than UMBMX: FSMDX (0.76) vs UMBMX (0.43). FSMDX was incepted earlier than UMBMX: FSMDX (15 years) vs UMBMX (20 years). UMBMX (0.98) is less costly to investors than FSMDX (0.03). UMBMX is a more actively managed with annual turnover of: 57.00 vs. FSMDX (15.00). FSMDX has a lower initial minimum investment than UMBMX: FSMDX (0) vs UMBMX (10000). FSMDX annual gain was more profitable for investors over the last year : 21.53 vs. UMBMX (13.01). FSMDX return over 5 years is better than : 47.15 vs. UMBMX (8.26).
FSMDXUMBMXFSMDX / UMBMX
Total Expense Ratio0.030.953%
Annual Report Gross Expense Ratio0.030.983%
Fund Existence15 years20 years-
Gain YTD17.73615.802112%
Front LoadN/AN/A-
Min. Initial Investment010000-
Min. Initial Investment IRAN/AN/A-
Net Assets52.1B4.26B1,223%
Annual Yield % from dividends0.760.43176%
Returns for 1 year21.5313.01165%
Returns for 3 years63.5941.20154%
Returns for 5 years47.158.26571%
Returns for 10 years166.8084.87197%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CBIO17.150.92
+5.67%
Crescent Biopharma Inc
ATLX3.320.15
+4.73%
Atlas Lithium Corp
CF129.603.90
+3.10%
CF Industries Holding
TARS72.701.21
+1.69%
Tarsus Pharmaceuticals
MASK1.47-0.02
-1.34%
3 E Network Technology Group Ltd